tirzepatide news today recency:3 New generic versions of are now under federal review. According to Healthline, federal regulators have agreed to review applications from Sandoz for generic versions of Mounjaro and Zepbound. While Eli Lilly FDA says the tirzepatide weight-loss

Evidence quality: Phase II RCT (human)

Liraglutide (Saxenda) NICE Technology Appraisal TA664 recommends liraglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, within a specialist weight management service

This dual mechanism makes it highly effective at regulating blood sugar, reducing appetite, and promoting feelings of fullness after meals

Because the medication slows down gastric emptying, some patients experience constipation

Following the schedule recommended by your provider at Royal Palm Beach Medical Group helps ensure safe and effective treatment